$0.14

0.00 (0.00%)
Live
Previous Close

$0.14

Day Range

$0 - $0

Previous Day Range

$0.14 - $0.14

Market Cap

$ USD

Day Vol.

0

Previous Day Vol.

2212

Currency

USD

Primary Exchange

None

NKGEN BIOTECH INC...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

NKGen Biotech secured $2 million in funding from a Japanese strategic investor to help regain compliance with reporting obligations and continue its NK cell therapy development, with plans to return to Nasdaq or NYSE American.

Related tickers: NKGN.

Read Full Article

NKGen Biotech, a clinical-stage biotechnology company, will present data on the use of its cell therapy, Troculeucel, for the treatment of Alzheimer's and Parkinson's disease at an upcoming biotechnology conference in China.

Related tickers: NKGN.

Read Full Article
Trending Tickers

Please sign in to view